Gina Pastino, PhD, DABT

Senior Director, Clinical Pharmacology
AbbVie

Poster(s):

• (87) Efficacy and safety of tavapadon, an orally administered, once-daily, selective D1/D5 dopamine agonist, adjunctive to levodopa for treatment of Parkinson’s disease with motor fluctuations
  Wednesday, October 29, 2025